Dehydroepiandrosterone Acetate | GMP-Certified DHEA API | ≥98% HPLC?
━━━━━━━━━━━━━━━━━━━━

?Product Overview?

Dehydroepiandrosterone Acetate (DHEA Acetate) is a synthetic steroid precursor widely utilized in hormone therapy formulations and anti-aging supplements?13. As a key intermediate in steroid biosynthesis, it supports the production of adrenal hormones, enhances metabolic regulation, and serves as a critical raw material for nutraceutical and pharmaceutical industries?24. Compliant with USP/EP standards, it ensures high bioactivity and batch consistency for API manufacturing?15.

?Key Advantages?

? ?≥98% HPLC-Verified Purity?: Meets pharmacopeial specifications for steroid intermediates, guaranteeing reliable hormonal activity?14.
? ?Stability-Tested?: 18-month shelf life under controlled conditions (20-25°C, protected from light and moisture)?36.
? ?GMP-Certified Production?: Traceable impurities (<0.5% total impurities) with batch-specific COA and ISO 9001:2025 compliance?25.

?Applications?

? ?Hormone Replacement Therapy (HRT)?: Core ingredient for adrenal insufficiency and menopause management formulations?36.
? ?Anti-Aging Supplements?: Key raw material for DHEA-based nutraceuticals targeting cellular rejuvenation?45.
? ?Sports Nutrition?: Enhances metabolic support in performance-enhancing supplements?13.

?Quality Certifications?

■ ?USP/EP Monograph Compliance?: Validated residual solvents (e.g., acetone <3000 ppm)?12.
■ ?ISO 17025 Accredited Testing?: ≤1.0% intra-batch variability confirmed by third-party laboratories?35.

?Market Trends?

The global DHEA market is projected to grow at ?CAGR 7.2% by 2030?, driven by rising demand for anti-aging and metabolic health products?46. DHEA Acetate accounts for ?12% of steroid precursor APIs?, with a 15% annual increase in clinical research procurement?25.